Principal Healthcare Innovators ETF (BTEC) |
| 39.49 0.4 (1.02%) 07-31 16:00 |
| Open: | 39.42 |
| High: | 39.62 |
| Low: | 39.42 |
| Volume: | 6,421 |
| Market Cap: | 16(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 48.00 |
| Resistance 1: | 41.10 |
| Pivot price: | 39.46 |
| Support 1: | 37.84 |
| Support 2: | 35.83 |
| 52w High: | 41.1 |
| 52w Low: | 25.66 |
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 31 May 2024
Finding Opportunity in Unloved Healthcare ETFs - ETF Trends
Wed, 22 Mar 2023
Healthcare Stocks List 2025: Best Publicly Traded Companies - Bullish Bears
Tue, 30 Mar 2021
Moderna ETFs to Gain on Positive 'Real-World' Study Data - Nasdaq
Tue, 02 Mar 2021
J&J's Vaccine Rollout a Shot in the Arm for These Biotech ETFs - ETF Trends
Tue, 19 May 2020
Moderna Helps This ETF, but It's not the Only Catalyst - ETF Trends
Wed, 14 Jan 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
